Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
about
Epigenetic therapy in gastrointestinal cancer: the right combinationBiomarkers of treatment toxicity in combined-modality cancer therapies with radiation and systemic drugs: study design, multiplex methods, molecular networksAdvances in epigenetic glioblastoma therapy.Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic RadiotherapyHistone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors.Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinicRational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancerBiomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy.Establishment of a patient-derived orthotopic osteosarcoma mouse modelCooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinomaHistone deacetylase inhibitor, valproic acid, radiosensitizes the C6 glioma cell line in vitro.Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array.Histone deacetylase inhibitor: antineoplastic agent and radiation modulatorRadiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes.Inhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation.Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model.Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat.Lupeol enhances radiosensitivity of human hepatocellular carcinoma cell line SMMC-7721 in vitro and in vivo.
P2860
Q26745709-F8DA34F9-8DE2-4784-B365-F3BA888F3B3EQ26991945-55F320EC-38E4-4224-8BF8-D278AC634390Q33567030-68B76188-BB05-44B1-B09E-4941B1AAF4CCQ33584050-3E2A3F74-D6A5-42BD-8579-0DD127230005Q34416994-0275D7DE-C2A8-4FAF-851C-671818384227Q35038016-A0579469-06E5-4D10-A079-2955F6E29C40Q35079955-2B9DCADC-7946-49A1-B980-D3A987CAE9B2Q35108007-87B83DFF-B886-4B74-ADC6-24EE566BFD99Q35595609-6DBB368B-A22F-4B1A-A1A6-5384E4C8E01AQ35627829-7E49987B-0366-46B8-BF72-2D80EC25FEF6Q35856816-CE4E3DB6-AAA8-40B5-8E86-F9596B1F33BEQ35927871-578FBCB7-070A-43A7-8065-DDC1D6FEA269Q36368072-7453CC0F-2B14-418B-96EB-1EA796ADE6E6Q37388728-1E9C69DC-944C-42DC-9756-D9595C907A3EQ37698595-A896AB2F-9081-4EF1-A52E-8B8151B9B126Q37929048-AB431BAD-017A-41D8-BEF1-A759FA61F65FQ38381001-4451C0D7-A44C-4929-A0B1-3780CDC3416EQ39079713-47B6716B-E947-45D5-A11A-6E7964319DA7Q39134963-B4724E81-20DA-4FFE-A676-CB51C9195AE3Q41347312-9799A041-345D-445E-8CB9-CD3487F52C45Q53017958-7AFB5ABC-9C0B-4039-A80B-17666B20F558
P2860
Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Radiosensitization by SAHA in ...... of histone acetylation status.
@en
Radiosensitization by SAHA in ...... of histone acetylation status.
@nl
type
label
Radiosensitization by SAHA in ...... of histone acetylation status.
@en
Radiosensitization by SAHA in ...... of histone acetylation status.
@nl
prefLabel
Radiosensitization by SAHA in ...... of histone acetylation status.
@en
Radiosensitization by SAHA in ...... of histone acetylation status.
@nl
P2093
P1476
Radiosensitization by SAHA in ...... of histone acetylation status.
@en
P2093
Sigurd Folkvord
Thomas Halvorsen
Torbjørn Furre
P304
P356
10.1016/J.IJROBP.2009.01.068
P407
P577
2009-06-01T00:00:00Z